MECHELEN, Belgium, 2024-Dec-08 — /EPR Network/ — Nipro PharmaPackaging, a global leader in glass tubing, glass primary packaging, and medical devices, is proud to announce the launch of its innovative D2F™ (Direct-to-Fill) glass vials.

These vials, featuring Stevanato Group’s advanced EZ-fill® technology, offer a high-quality ready-to-use (RTU) solution designed to meet the rigorous standards and increasing requirements of the pharmaceutical industry.

Key Features of D2F™ Glass Vials

·        Direct-to-Fill Technology:
D2F™ glass vials are washed, depyrogenated, packaged in nest & tub formats, and sterilized providing a seamless RTU solution.
Pharmaceutical companies can integrate these vials directly into their aseptic fill-finish processes.·        Optimized for Fill-Finish Lines:
Developed in collaboration with leading machine suppliers, D2F™ vials are compatible with a wide range of fill-finish lines, ensuring easy and quick integration, thus speeding up operations.·        Increased Stability & Cost Efficiency:
D2F™ vials’ nest & tub design prevents glass-to-glass contact, reducing risks of breakage, cosmetic defects, and particle generation during transportation and handling.This results in improved mechanical durability, lower downtime, and fewer rejections during final inspections, ultimately contributing to more stable and cost-efficient fill-finish operations.Quote Nipro :
“We are excited to introduce D2F™ glass vials, offering a reliable and efficient RTU packaging solution that addresses the evolving needs of the pharmaceutical industry,” said Stephan Arnold, CEO Nipro PharmaPackaging.

“These vials exemplify our mission to delivering trust with premium primary pharma packaging solutions.”

Quote Stevanato :

“The collaboration with Nipro represents another important milestone for Stevanato Group’s EZ-fill® pre-sterilized platform,” said Mauro Stocchi, Chief Business Officer at Stevanato Group. “Nipro’s adoption of the EZ-fill® platform further validates Stevanato Group’s technological leadership and strengthens our market position in secondary packaging for aseptic manufacturing. The EZ-fill® platform is an increasingly reliable, scalable, and cost-effective solution and industry-validated technology, and we believe it will become a widely recognized standard in the industry.”

 

For more information on D2F™ glass vials, visit [Nipro’s website]
(https://www.nipro-group.com).About Nipro:
Nipro PharmaPackaging specializes in the development and manufacturing of advanced pharmaceutical packaging products and complete packaging solutions for early-stage drug development or the enhancement of packaging solutions for existing pharmaceutical drugs.Nipro PharmaPackaging is part of Nipro Corporation Japan, a leading global healthcare company founded in 1954 in Osaka with close to 40.000 colleagues worldwide.Nipro Corporation serves the Medical Device, Pharmaceutical, Pharma Packaging and Regeneritive Medicine sectors.

About Stevanato Group:

Founded in 1949, Stevanato Group is a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. The Group delivers an integrated, end-to-end portfolio of products, processes and services that address customer needs across the entire drug life cycle at each of the development, clinical and commercial stages. Stevanato Group’s core capabilities in scientific research and development, its commitment to technical innovation and its engineering excellence are central to its ability to offer value added solutions to clients. To learn more, visit: www.stevanatogroup.com.